Orchid Pharma Limited disclosed that its Board of Directors took note of notices received from the National Stock Exchange of India Limited (NSE) and BSE Limited. The notices, dated October 30, 2026, imposed a fine of ₹2,000 each on the company for a one-day delay in filing its Annual Report for the financial year 2025-26 with the stock exchanges. This delay constituted non-compliance with Regulation 34 of the SEBI Listing Regulations.
The Board noted that the fines, along with the applicable GST of 18% (₹360 each, totaling ₹2,360 per exchange), had been paid. The Board advised the management to exercise due caution and strengthen the internal compliance monitoring mechanism to ensure timely submission of all statutory and regulatory filings and to avoid a recurrence of such instances in the future.
The original notices from the exchanges referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, issued on July 11, 2023, and last updated on January 30, 2026. The NSE notice (Ref: NSE/LIST-SOP/COMB/FINES/1209) specified the non-compliance was for the year ending March 31, 2026. The BSE notice (Ref: SOP-Review/30-10-2026) also listed a potential fine of ₹25,000 for non-disclosure of a Dividend Distribution Policy under Regulation 43A for the same period, but this fine amount was shown as ₹0, indicating the company was likely compliant on that specific regulation.
Both exchanges warned that failure to pay the fines within 15 days could lead to the freezing of the entire shareholding of the company's promoters in their demat accounts. Furthermore, they stated that a second consecutive year of non-compliance with Regulation 34 would result in the company's securities being shifted to a 'Trade for Trade' basis (Z Category) and could lead to suspension of trading.
The exchanges also mandated that the matter be placed before the company's Board, and the Board's comments were to be communicated back to the exchanges for dissemination, which was the purpose of this filing. The company was required to submit these comments via the NEAPS portal under the path: NEAPS > COMPLIANCE > Announcements > Announcements/ CA with the subject 'Board comments on fine levied by the Exchange'.